稳心颗粒治疗冠心病室性早搏45例临床观察

目的：观察稳心颗粒治疗冠心病室性早搏的疗效。方法：将90例冠心病室性早搏患者随机分为治疗组和对照组各45例,两组均以冠心病常规治疗,对照组予比索洛尔片治疗,治疗组予比索洛尔片联用稳心颗粒治疗。疗程均为4周。结果：24h动态心电图显示两组室性早搏治疗后均比治疗前有明显好转（对照组治疗后vs.治疗前=1029±1090vs.2566±2600,治疗组治疗后vs.治疗前=366±402vs.2602±2620,P〈0.05）,从平均改善值来看,治疗组改善程度更高,早搏次数减少更多（对照组vs.治疗组=1502±1892vs.2319±1662,P〈0.05）。治疗组总有效率高于对照组（93.3%vs.57.8%,P〈0.05）。结论：稳心颗粒治疗冠心病室性早博有明显疗效。

Effect of Wenxin Granule on 45 cases of Coronary Heart Disease Patients with Ventricular Premature Beat

Objective：To observe the clinical efficacy of Wenxin Granule on coronary heart disease patients with ventricular premature beat. Methods： The 90 patients with regular treatment of coronary heart disease were randomly divided into treatment and control groups, 45 cases in each. Patients were given routine treatment for coronary heart disease in two groups. Patients were treated by Metoprolol in control group, and Metoprolol plus Wenxin Granule in treatment group. The treatment course was 4 weeks in two groups. Results： The 24 hours DCG showed the ventrieular premature beat was relieved both in two groups （after vs. before=1029±1090 vs. 2566±2600 in control group, after vs. before=366±402 vs. 2602±2620 in treatment group, P〈0.05）. On mean improvement from value perspective, the treatment group improved more and reduced the number of premature more （control group vs. treatment group =1502±1892vs.2319±1662, P〈0.05）.The efficacy in the treatment group was superior to that in the control group（93.3% vs. 57.8%, P〈0.05）. Conclusion： Wenxin Granule has definite effect on ventrieular premature beat in patients with coronary heart disease.